Jianjun Zou

9.6k total citations · 1 hit paper
184 papers, 4.0k citations indexed

About

Jianjun Zou is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jianjun Zou has authored 184 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Pulmonary and Respiratory Medicine, 48 papers in Oncology and 33 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jianjun Zou's work include Acute Ischemic Stroke Management (21 papers), Antiplatelet Therapy and Cardiovascular Diseases (20 papers) and Cancer Immunotherapy and Biomarkers (18 papers). Jianjun Zou is often cited by papers focused on Acute Ischemic Stroke Management (21 papers), Antiplatelet Therapy and Cardiovascular Diseases (20 papers) and Cancer Immunotherapy and Biomarkers (18 papers). Jianjun Zou collaborates with scholars based in China, United States and Australia. Jianjun Zou's co-authors include Yubing Zhu, Xiaoyu Zhu, Linna Wang, Shukui Qin, Jianping Xiong, Zhiqiang Meng, Zhendong Chen, Qianming Du, Zhenggang Ren and Yuxian Bai and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jianjun Zou

175 papers receiving 3.9k citations

Hit Papers

Camrelizumab in patients with previously treated advanced... 2020 2026 2022 2024 2020 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial
    2020 418 citations Zhiqiang Meng, Jianping Xiong et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianjun Zou China 33 1.6k 1.1k 939 540 491 184 4.0k
Yan Sun China 30 1.3k 0.8× 1.4k 1.3× 1.3k 1.4× 274 0.5× 571 1.2× 130 3.6k
Akira Tangoku Japan 35 1.1k 0.7× 1.2k 1.1× 1.4k 1.5× 385 0.7× 750 1.5× 243 4.5k
Lei Feng China 30 914 0.6× 548 0.5× 959 1.0× 279 0.5× 667 1.4× 255 3.7k
Kwangmo Yang South Korea 31 680 0.4× 671 0.6× 912 1.0× 186 0.3× 428 0.9× 167 3.0k
Romain Coriat France 40 2.7k 1.7× 1.6k 1.6× 760 0.8× 1.1k 2.1× 583 1.2× 287 5.2k
In Ja Park South Korea 33 2.8k 1.7× 810 0.8× 867 0.9× 535 1.0× 351 0.7× 227 4.7k
Wei Guo China 42 2.5k 1.6× 912 0.9× 2.3k 2.4× 812 1.5× 1.9k 3.9× 172 7.2k
Shigemi Matsumoto Japan 26 1.6k 1.0× 636 0.6× 866 0.9× 263 0.5× 380 0.8× 136 3.2k
Chikuma Hamada Japan 28 897 0.6× 1.1k 1.0× 418 0.4× 411 0.8× 193 0.4× 144 3.5k
Eliane Angst Switzerland 20 1.7k 1.0× 1.1k 1.1× 1.0k 1.1× 891 1.6× 811 1.7× 36 4.9k

Countries citing papers authored by Jianjun Zou

Since Specialization
Citations

This map shows the geographic impact of Jianjun Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianjun Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianjun Zou more than expected).

Fields of papers citing papers by Jianjun Zou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianjun Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianjun Zou. The network helps show where Jianjun Zou may publish in the future.

Co-authorship network of co-authors of Jianjun Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Jianjun Zou. A scholar is included among the top collaborators of Jianjun Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianjun Zou. Jianjun Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yan, Yuqing, Zhou Zhou, Jifan Zhang, et al.. (2024). Accurate prediction of bleeding risk after coronary artery bypass grafting with dual antiplatelet therapy: A machine learning model vs. the PRECISE-DAPT score. International Journal of Cardiology. 421. 132925–132925. 3 indexed citations
3.
Zou, Jianjun, Xuefa Shi, Zhengquan Yao, et al.. (2024). Abrupt enhanced Pacific warm water intrusion into the Sea of Okhotsk since the early Holocene. Quaternary Science Reviews. 345. 109026–109026. 1 indexed citations
4.
Si, Yanna, et al.. (2024). Machine learning-based risk prediction of hypoxemia for outpatients undergoing sedation colonoscopy: a practical clinical tool. Postgraduate Medicine. 136(1). 84–94. 3 indexed citations
5.
Li, Junlin, et al.. (2023). A risk prediction model based on machine learning for postoperative cognitive dysfunction in elderly patients with non-cardiac surgery. Aging Clinical and Experimental Research. 35(12). 2951–2960. 7 indexed citations
6.
7.
8.
Xiang, Liang, Feng Zhou, Mengyi Xu, et al.. (2023). Dynamic and visual nomograms to online predict unfavorable outcome of mechanical thrombectomy for acute basilar artery occlusion. Brain and Behavior. 13(12). e3297–e3297. 2 indexed citations
9.
Lu, Rongzhu, et al.. (2023). Assessing hypertension and diabetes knowledge, attitudes and practices among residents in Akatsi South District, Ghana using the KAP questionnaire. Frontiers in Public Health. 11. 1056999–1056999. 7 indexed citations
10.
Feng, Jifeng, Jing Wang, Qi Zhou, et al.. (2022). SHR-1701, a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, for Recurrent or Metastatic Cervical Cancer: A Clinical Expansion Cohort of a Phase I Study. Clinical Cancer Research. 28(24). 5297–5305. 42 indexed citations
11.
Chen, Tingting, et al.. (2022). Machine Learning-Assisted Preoperative Diagnosis of Infection Stones in Urolithiasis Patients. Journal of Endourology. 36(8). 1091–1098. 7 indexed citations
12.
Qin, Shukui, Shanzhi Gu, Zhenggang Ren, et al.. (2021). Camrelizumab plus oxaliplatin‐based chemotherapy as first‐line therapy for advanced biliary tract cancer: A multicenter, phase 2 trial. International Journal of Cancer. 149(11). 1944–1954. 38 indexed citations
13.
Lu, Juming, Yan Li, Li Qin, et al.. (2021). Henagliflozin monotherapy in patients with type 2 diabetes inadequately controlled on diet and exercise: A randomized, double‐blind, placebo‐controlled, phase 3 trial. Diabetes Obesity and Metabolism. 23(5). 1111–1120. 16 indexed citations
14.
Jiang, Liang, Leilei Zhou, Wei Yong, et al.. (2021). A deep learning‐based model for prediction of hemorrhagic transformation after stroke. Brain Pathology. 33(2). e13023–e13023. 29 indexed citations
15.
Liu, Peihua, Weimin Kong, Ping Li, et al.. (2021). PXR activation impairs hepatic glucose metabolism partly via inhibiting the HNF4α–GLUT2 pathway. Acta Pharmaceutica Sinica B. 12(5). 2391–2405. 30 indexed citations
16.
Lickliter, Jason D., Hui Gan, Mark Voskoboynik, et al.. (2020). <p>A First-in-Human Dose Finding Study of Camrelizumab in Patients with Advanced or Metastatic Cancer in Australia</p>. Drug Design Development and Therapy. Volume 14. 1177–1189. 26 indexed citations
17.
Chen, Zuhua, Yingying Xu, Jifang Gong, et al.. (2020). Pyrotinib combined with CDK4/6 inhibitor in HER2‐positive metastatic gastric cancer: A promising strategy from AVATAR mouse to patients. SHILAP Revista de lepidopterología. 10(4). e148–e148. 25 indexed citations
18.
Situ, Bo, Xinyi Ye, Qianwen Zhao, et al.. (2020). Identification and Single‐Cell Analysis of Viable Circulating Tumor Cells by a Mitochondrion‐Specific AIE Bioprobe. Advanced Science. 7(4). 1902760–1902760. 40 indexed citations
19.
Ma, Fei, Quchang Ouyang, Wěi Li, et al.. (2019). Pyrotinib or Lapatinib Combined With Capecitabine in HER2–Positive Metastatic Breast Cancer With Prior Taxanes, Anthracyclines, and/or Trastuzumab: A Randomized, Phase II Study. Journal of Clinical Oncology. 37(29). 2610–2619. 247 indexed citations
20.
Wang, Jie, Jianjun Zou, Yong Gao, et al.. (2005). Double-blinded, Controlled, Randomized Study of Dihydrocodeine Tartrate vs Codeine Phosphate in Treating Cancer Pain. The Chinese-German Journal of Clinical Oncology. 4(2). 108–111. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yan Sun Breakdown of academic impact, for papers by Akira Tangoku Breakdown of academic impact, for papers by Lei Feng Breakdown of academic impact, for papers by Kwangmo Yang Breakdown of academic impact, for papers by Romain Coriat Breakdown of academic impact, for papers by In Ja Park Breakdown of academic impact, for papers by Wei Guo Breakdown of academic impact, for papers by Shigemi Matsumoto Breakdown of academic impact, for papers by Chikuma Hamada Breakdown of academic impact, for papers by Eliane Angst
Rankless by CCL
2026